Researchers at the Centenary Institute and the University of Sydney have developed a new COVID-19 vaccine candidate that demonstrates strong potential to protect against both current and emerging coronavirus variants. The vaccine targets shared features among various coronaviruses, aiming to provide broader and longer-lasting protection as the virus evolves. CoVEXS5 Protects Against Multiple Coronaviruses, Including … Australia Develops Supercharged COVID-19 Vaccine That Fights Future Variants Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.